The adjusted UTS 100K podium
Finished third in the 2025 women’s UTS 100K in 17:06:34.
Event date: 2025 · TUM publication: May 23, 2025
Athlete
Kimino Miyazaki is a trail runner and researcher. Her North Face profile describes an interest in the exercise physiology of mountaineering and how that work connects with her running.
2 TUM reports · Published coverage below
Publication history
2 editorial issues
Distinct issues per publication month. Each issue counts once.
Monthly editorial issue counts: Jul 2024: 0; Aug 2024: 0; Sep 2024: 0; Oct 2024: 0; Nov 2024: 0; Dec 2024: 0; Jan 2025: 0; Feb 2025: 1; Mar 2025: 0; Apr 2025: 0; May 2025: 1; Jun 2025: 0; Jul 2025: 0; Aug 2025: 0; Sep 2025: 0; Oct 2025: 0; Nov 2025: 0; Dec 2025: 0; Jan 2026: 0; Feb 2026: 0; Mar 2026: 0; Apr 2026: 0; May 2026: 0; Jun 2026: 0; Jul 2026: 0; Aug 2026: 0; Sep 2026: 0; Oct 2026: 0; Nov 2026: 0.
Sponsor mentions, repeated links and polls are excluded. Credits within editorial items may count. Read the supporting timeline ↓
Newest first
Finished third in the 2025 women’s UTS 100K in 17:06:34.
Event date: 2025 · TUM publication: May 23, 2025
Won the women’s 2025 Tarawera 100-mile race after two previous near misses.
Event date: 2025 · TUM publication: February 21, 2025
Facts above link directly to their sources. Published TUM dates and public-source check dates describe different things.
Public background sources checked October 28, 2026. The selection contains 127 published issues.
Career context from one original public source. TUM’s dated reporting appears below.
This is a limited career snapshot, checked October 28, 2026. Source publication dates and event dates are shown separately.
Published article, 2025-05-23T14:54:23.342Z. Public original captured at 2026-10-28T02:39:04.246Z and projected to reviewed article text; no publishing-repository text pin is claimed.
Published article, 2025-02-21T01:34:56.246Z. Public original captured at 2026-10-30T03:34:14.166Z and projected to reviewed article text; no publishing-repository text pin is claimed.